Frontlight ResearchEarly access
Trial site
Centro Regional Integrado de Oncologia
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Ovarian cancer3 trials
- Phase
- Phase 36 trials
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Taiho Oncology, Inc.2 trials
- Tolmar Inc.2 trials
- AstraZeneca1 trial
- BioNTech SE1 trial
- Incyte Corporation1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Enrolling by invitation
Active, not recruiting
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026